Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
  1. Home
  2. Publications
  3. Supplementary Figure S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model

Supplementary Figure S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model

Authors:
  • SCShih-Shih Chen
    Shih-Shih Chen
  • JBJacqueline C. Barrientos
    Jacqueline C. Barrientos
  • GFGerardo Ferrer
    Gerardo Ferrer
  • MKMorgan King-Richards
    Morgan King-Richards
  • YCYu-Ju Chen
    Yu-Ju Chen
  • PRPriyadarshini Ravichandran
    Priyadarshini Ravichandran
  • MIMichael Ibrahim
    Michael Ibrahim
  • YKYasmine Kieso
    Yasmine Kieso
  • SWSheila Waters
    Sheila Waters
  • JKJeffery L. Kutok
    Jeffery L. Kutok
  • MPMarisa Peluso
    Marisa Peluso
  • SSSujata Sharma
    Sujata Sharma

Open Access
Publisher website
Google Scholar
  • 15 May 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.22820110.v1
Abstract
Effects of inhibition of PI3K isoforms on CLL-cell proliferation, survival, and migration.
Keywords
  • SUPPLEMENTARY FIGURE
  • DUVELISIB ELIMINATES
  • ELIMINATES CLL
  • OVERCOMES IBRUTINIB
  • IBRUTINIB RESISTANCE
  • XENOGRAFT MODEL
  • MODEL EFFECTS
  • IMPAIRS CLL-SUPPORTING
  • CLL-SUPPORTING CELLS
  • CLL-CELL PROLIFERATION
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.